Nigeria #11224 (v.1)
Base data
- Notified in
-
G/MA/QR/N/NGA/1 17/09/2026
- Version validity
-
01/05/2026 -
present
Current active version v.1
- Reporting member
- Nigeria
- In force from
- End date
- In force
- General description
-
Import prohibition of certain pharmaceuticals
- National legal basis
-
2026 Fiscal Policy Measures (Entry into force: 1 May 2026)
- Administrative mechanism
-
Goods can be imported on the condition that they are not for sale, distribution, manufacturing, processing or any commercial activity. They are intended for personal use only.
- Responsible entities
-
- HS version
-
HS 2022
- Referenced WTO document symbol
Meta data
- WTO justifications
-
Article XVIII - Article XVIII* -Governmental Assistance to Economic Development
GATT 1994 (GATT 1947 provisions)
Reported as: GATT XVIII: B - Non-WTO commitments
-
- Affected partners
- Non-affected partners
Measures
- Reported restrictions
- CP
| Symbol |
|---|
|
CP
|
Tariff lines
|
300410
|
3004.1000.00
|
Ointments penicillin/gentamycin
|
|
|
300420
|
3004.2000.00
|
Cotrimoxazole tablets and syrups, Metronidazole tablets and syrups
|
|
|
300450
|
3004.5000.00
|
Haematinic formulations: Folic acid tablets, Vitamin B Complex tablets (except modifies release form...
|
|
|
300460
|
3004.6000.00
|
Chloroquine tablets and syrups
|
|
|
300490
|
3004.9090.00
|
Haematinic formulations: Ferrous Sulphate and Ferrous gluconate tablets, Aspirin tablets (except mod...
|
|